Zacks.com featured highlights: ANI Pharmaceuticals, Cooper-Standard Holdings, Berry Plastics Group, Amkor Technology and Power Integrations

Loading...
Loading...

For Immediate Release

Chicago, IL – August 23, 2016 - Stocks in this week's article include: ANI Pharmaceuticals, Inc. ANIP, Cooper-Standard Holdings Inc. (CPS), Berry Plastics Group Inc. BERY, Amkor Technology, Inc. AMKR and Power Integrations Inc. POWI.

Screen of the Week of Zacks Investment Research:

High-Flying Stocks with More Room to Run

It is true that relying on stock screeners can be a potent technique to make most of the market trends and compound returns. However, there is no one single rule or a crystal ball that can help one pick winners in the finance universe.

A particular strategy advises investors to gamble on stocks that have scaled to 52-week highs. While very few may deem it to be rational to invest in a stock which is going up, the trick is to discover soaring stocks that are still undervalued with strong upside potential.

This is where our screener comes into play as it helps you to set the correct parameters with the 52-week high criteria.

Why Bet on Stocks at 52-Week Highs?

Loading...
Loading...

Stocks nearing 52-week high often instill the presumptive "adjustment and anchoring bias" principle in the minds of investors. This principle works on the belief that investors use the 52-week high price as a reference point and value stocks against this anchor. They fear that the stocks are overvalued and a price crash is impending. Thus, their psychological bias prevents them from adding positions on such stocks.

In such a situation, these stocks are prevented from scaling higher despite robust potential, due to the psychological reservations of investors.

It takes thorough understanding to tell diamonds from ordinary pebbles, and a few of the stocks remain undervalued due to prolonged under reaction on the part of investors, despite bullish growth drivers. News pertaining to robust sales, surging profit levels, bullish earnings prospects and strategic acquisitions can drive the stock higher.

However, when a string of positive developments start dominating the market, investors find their under-reaction unwarranted as the renewed interest might push stocks beyond the 52-week high bar. Thus, the trick is to get into the betting game before everyone else.

Setting the Right Filters

Make no mistake, 52 week-high stocks have their own share of pitfalls, which might prove perilous. Relying on ad hoc strategies and following price movements blindly carry great risk.

Using our reliable screening technique, we have singled out 52-week highs which still have strong prospects relative to their respective industries. Positive momentum in the stock price blended with strong earnings growth expectations and great value metrics, we believe these stocks will continue their uptrend for quite some time.

We have also made sure these stocks are relatively undervalued compared to their peers, in terms of earnings as well as sales.

Current Price/52 Week High >= .80

This simply is the ratio between the current price and the highest price at which the stock has traded in the past 52 weeks. A value greater than 0.8 implies that the stock is trading within 20% of its 52-week high range and is likely to touch the 52-week mark soon.

% Change Price – 4 Weeks > 0

It ensures that the price of the stock has moved north over the past four weeks.

% Change Price – 12 Weeks > 0

This metric guarantees a continued upward price momentum for the stock over the past three months as well.

Price/Sales <= XIndMed

Lower the ratio, the better for investors as they have to pay lesser price for the same amount of sales.

P/E using F(1) Estimate <= XIndMed

This metric measures the amount an investor puts into a company to obtain one dollar of earnings. It narrows down the list of stocks to those that are undervalued compared to their peers.

One-Year EPS Growth F(1)/F(0) >= XIndMed

This metric helps zero in on stocks that have growth rates higher than the industry median. This is a meaningful indicator as decent earnings growth adds to investor optimism.

Zacks Rank = 1

No screening is complete without our proven Zacks Rank, which has proved its worth since inception. It is a fundamental truth that stocks with a Zacks Rank #1 (Strong Buy) or #2 (Buy) have always managed to brave adversities and outperform the market.

Current Price >= 5

This parameter will help in screening stocks which are trading at a minimum of $5 or higher.

Volume – 20 days (shares) >= 100000

Inclusion of this metric ensures that there is a substantial volume of shares that can be traded easily.

Here are seven of the 21 stocks that made it through the screen:

ANI Pharmaceuticals, Inc. (ANIP): This specialty pharmaceutical company is engaged in developing, manufacturing, marketing branded and generic prescription pharmaceuticals. ANI Pharmaceuticals has managed to beat estimates in two out of four times in the trailing four quarters, resulting in an average positive surprise of 46.8%.

Cooper-Standard Holdings Inc. (CPS): The company operates as a supplier of systems and components for the automotive industry. Its products include sealing and trim, fuel and brake delivery, fluid transfer, thermal and emissions and anti-vibration systems. Cooper-Standard managed to beat estimates in all of the trailing four quarters, clocking an average positive surprise of 51.2%.

Berry Plastics Group Inc. (BERY): The company is engaged in manufacturing and marketing of value-added plastic consumer packaging and engineered materials. Berry Plastics managed to beat estimates in three out of the trailing four quarters, the average positive surprise being 14.0%.

Amkor Technology, Inc. (AMKR): The company is the world's largest independent provider of semiconductor packaging and test services. Also, it is one of the leading developers of advanced semiconductor packaging and test technology. The company managed to beat earnings every time in the last four quarters and has an average positive surprise of 131.2%.

Power Integrations Inc. (POWI): The company is engaged in designing, developing, manufacturing and marketing proprietary, high-voltage, analog integrated circuits that are extensively deployed in alternating current to direct current power conversion. It has an average positive surprise of 20.6%.

You can get the rest of the stocks on this list by signing up now for your 2-week free trial to the Research Wizard and start using this screen in your own trading. Further, you can also create your own strategies and test them first before taking the investment plunge.

The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your trial to the Research Wizard today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.

Click here to sign up for a free trial to the Research Wizard today

Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.

Disclosure: Performance information for Zacks' portfolios and strategies are available at: https://www.zacks.com/performance .

Zacks Restaurant Recommendations: In addition to dining at these special places, you can feast on their stock shares. A Zacks Special Report spotlights 5 recent IPOs to watch plus 2 stocks that offer immediate promise in a booming sector. Download it free »

Sign up now for your free trial today and start picking better stocks immediately. And with the backtesting feature, you can test your ideas to see how you can improve your trading in both up markets and down markets. Don't wait for the market to get better before you decide to do better. Start learning how to be a better trader today: https://at.zacks.com/?id=111

Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.

About Screen of the Week

Zacks.com created the first and best screening system on the web earning the distinction as the "#1 site for screening stocks" by Money Magazine. But powerful screening tools is just the start. That is why Zacks created the Screen of the Week to highlight profitable stock picking strategies that investors can actively use. Each week, Zacks Profit from the Pros free email newsletter shares a new screening strategy. Learn more about it here https://at.zacks.com/?id=112

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978. The later formation of the Zacks Rank, a proprietary stock picking system; continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Click here for your free subscription to Profit from the Pros.

Follow us on Twitter: https://twitter.com/zacksresearch

Join us on Facebook: https://www.facebook.com/ZacksInvestmentResearch

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Contact: Jim Giaquinto
Company: Zacks.com
Phone: 312-265-9268
Email: pr@zacks.com

Visit: https://www.zacks.com/performance

Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer .

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.
Click to get this free report

ANI PHARMACEUT ANIP: Free Stock Analysis Report

COOPER-STANDARD (CPS): Free Stock Analysis Report

BERRY PLASTICS BERY: Free Stock Analysis Report

AMKOR TECH INC AMKR: Free Stock Analysis Report

POWER INTGRATIO POWI: Free Stock Analysis Report

To read this article on Zacks.com click here.
Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...